Lung Diseases clinical trials

Explore recruiting lung diseases clinical trials.

Recruiting lung diseases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lung Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung Disease

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Assessment of the effect of Wharton's jelly mesenchymal stem cell preparation (WJMSCs) in the treatment of fibrotic interstitial lung diseases

Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Netherlands, Greece, Slovenia, Germany, Hungary, France +13 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis

Netherlands, Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with interstitial lung disease (ILD) associated with connective tissue disease (CTD).

Belgium, Netherlands, Germany, France, Greece, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Lung Diseases trials by city

Lung Diseases in Toronto Lung Diseases in Vancouver Lung Diseases in Montreal Lung Diseases in Calgary Lung Diseases in Edmonton Lung Diseases in Ottawa Lung Diseases in Winnipeg Lung Diseases in Quebec City Lung Diseases in Hamilton Lung Diseases in Kitchener Lung Diseases in London Lung Diseases in Halifax Lung Diseases in New York Lung Diseases in Los Angeles Lung Diseases in Chicago Lung Diseases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease